ACMG	the American College of Medical Genetics and Genomics
ASCO-CAP	the American Society of Clinical Oncology and the College of American Pathologists
BC	breast cancer
Cdk2	cyclin-dependent kinase 2
CGH	comparative genome hybridization
CISH	chromogenic in situ hybridization
CTC	circulating tumor cells
DAB	3,3′-diaminobenzidine;
DFSP	dermatofibrosarcoma protuberans
DSBs	double-stranded breaks
EGFR	epidermal growth factor receptor
ES	Ewing sarcoma
EZR	Ezrin
FDA	U.S. Food and Drugs Administration
FFPE	formalin-fixed paraffin-embedded
FISH	fluorescence in situ hybridization
G-banding	Giemsa-banding
H&E	Hematoxylin and Eosin
HCl	hydrochloric acid
HGF	hepatocyte growth factor
HGSOC	high-grade serous ovarian carcinoma
HRP	horseradish peroxidase
HR	homologous recombination
hsr	homogeneously staining region
IHC	Immunohistochemistry
KLC1	kinesin light chain 1
LOH	loss of heterozygosity
MAPK	mitogen-activated protein kinases
MLPA	multiplex ligation probe amplification
mRNA	messenger ribonucleic acid
NCNN	the National Comprehensive Cancer Network;
NGS	next-generation sequencing
NSCLC	non-small cell lung cancer
PDGFB	platelet-derived growth factor beta
RT-PCR	reverse transcriptase-polymerase chain reaction
SDC4	syndecan 4
SIOP	the International Society of Pediatric Oncology
SS	synovial sarcoma
SSC	saline-sodium citrate
STS	soft tissue sarcomas
TKI	tyrosine kinase inhibitors
TP53	tumor protein 53
TPM3	tropomyosin 3